Home/Filings/4/0001193125-26-001172
4//SEC Filing

MORTIMER IAN 4

Accession 0001193125-26-001172

CIK 0001582313other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 6:49 PM ET

Size

11.6 KB

Accession

0001193125-26-001172

Insider Transaction Report

Form 4
Period: 2026-01-02
MORTIMER IAN
DirectorPRESIDENT & CEO
Transactions
  • Exercise/Conversion

    Common Shares

    2026-01-02$7.49/sh+40,000$299,60046,000 total
  • Sale

    Common Shares

    2026-01-02$44.40/sh37,938$1,684,4478,062 total
  • Sale

    Common Shares

    2026-01-02$44.93/sh2,062$92,6466,000 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2026-01-0240,0000 total
    Exercise: $7.49Exp: 2026-03-10Common Shares (40,000 underlying)
Holdings
  • Common Shares

    (indirect: By Spouse)
    14,300
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.
  • [F2]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $43.91 to $44.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F3]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $44.91 to $45.125, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F4]The shares subject to the option are fully vested and exercisable.

Documents

1 file

Issuer

Xenon Pharmaceuticals Inc.

CIK 0001582313

Entity typeother

Related Parties

1
  • filerCIK 0001619961

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 6:49 PM ET
Size
11.6 KB